Recommended Approach for Starting Blood Pressure Medications
For patients with hypertension, the recommended approach is to start with a low-dose ACE inhibitor or ARB for non-black patients, and a low-dose ARB plus dihydropyridine calcium channel blocker (DHP-CCB) or DHP-CCB plus thiazide/thiazide-like diuretic for black patients, with subsequent dose adjustments based on blood pressure response. 1
Initial Assessment and Treatment Decision
- Confirm hypertension diagnosis with office BP ≥140/90 mmHg, particularly if home BP ≥135/85 mmHg or 24h ambulatory BP ≥130/80 mmHg 1
- Determine hypertension severity:
Treatment Algorithm Based on Patient Characteristics
For Non-Black Patients:
- Start with low-dose ACE inhibitor (e.g., lisinopril 10 mg daily) or ARB (e.g., losartan 50 mg daily) 1, 2, 3
- Increase to full dose if blood pressure remains uncontrolled (e.g., lisinopril 20-40 mg, losartan 100 mg) 2, 3
- Add thiazide/thiazide-like diuretic if target BP not achieved 1
- Add spironolactone or alternatives (amiloride, doxazosin, eplerenone, clonidine, beta-blocker) if needed 1
For Black Patients:
- Start with low-dose ARB (e.g., losartan 50 mg daily) plus DHP-CCB or DHP-CCB plus thiazide/thiazide-like diuretic 1, 3
- Increase to full dose if blood pressure remains uncontrolled 1
- Add diuretic or ACE/ARB if not already included 1
- Add spironolactone or alternatives (amiloride, doxazosin, eplerenone, clonidine, beta-blocker) if needed 1
Special Considerations
For elderly patients (>80 years) or frail individuals: Consider monotherapy at lower starting doses 1
For patients with renal impairment:
Dosing Strategies and Monitoring
- Use once-daily dosing and single-pill combinations when possible to improve adherence 1, 4
- Target BP should be <130/80 mmHg for most patients, with a minimum reduction of 20/10 mmHg 1, 4
- Monitor BP control and aim to achieve target within 3 months 1
- Low doses are often effective and well-tolerated; adding a second agent at low dose is preferable to maximizing the dose of a single agent to avoid adverse effects 5
Common Pitfalls to Avoid
- Underdosing medications: Many physicians prescribe lower doses than those proven effective in clinical trials 6
- Failing to initiate combination therapy in high-risk patients: Evidence suggests patients with high cardiovascular risk benefit from starting immediately on combination therapy 7
- Inadequate follow-up: Regular monitoring is essential to assess efficacy and adjust therapy accordingly 1
- Not accounting for racial differences in treatment response: Black patients typically respond better to calcium channel blockers and diuretics than to ACE inhibitors or ARBs as monotherapy 1